Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans - PubMed (original) (raw)
Review
Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans
N D Volkow et al. J Psychopharmacol. 1999 Dec.
Abstract
We summarize our studies with positron emission tomography investigating the role of dopamine (DA) in the reinforcing effects of cocaine and methylphenidate in humans and its involvement in cocaine addiction. These studies have shown that the rate at which cocaine and methylphenidate enter the brain and block the dopamine transporters (DAT) is the variable associated with the 'high', rather than the presence per se of the drug in the brain. Our studies also show that, while the level of DAT blockade is important in predicting the intensity of the 'high' induced by these drugs (DAT blockade > 50% is required for these drugs to induce a 'high'), the rate at which DAT are blocked determines whether the 'high' is perceived or not. Thus, oral methylphenidate, which leads to slow DAT blockade, does not induce a 'high', even at doses which block DAT more than 60%. In cocaine abusers, we have shown significant reductions in DA D2 receptors that are associated with decreased metabolism in cingulate gyrus and in orbitofrontal cortex. We suggest that this is one of the mechanisms by which DA disruption leads to compulsive drug administration in cocaine addiction. Cocaine abusers also show significant decreases in DA release, which coupled with the reduction in D2 receptors may result in decreased activation of reward circuits by physiological reinforcers and may perpetuate cocaine use as a means to compensate for this deficit. Thus, strategies to enhance DA brain function in ways that mimic physiological DA activity may be of help in overcoming cocaine addiction.
Similar articles
- Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM. Volkow ND, et al. Synapse. 2002 Mar 1;43(3):181-7. doi: 10.1002/syn.10038. Synapse. 2002. PMID: 11793423 - Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high".
Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Dewey SL, Hitzemann R, Gifford AN, Pappas NR. Volkow ND, et al. J Pharmacol Exp Ther. 1999 Jan;288(1):14-20. J Pharmacol Exp Ther. 1999. PMID: 9862747 - Relationship between subjective effects of cocaine and dopamine transporter occupancy.
Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea CE. Volkow ND, et al. Nature. 1997 Apr 24;386(6627):827-30. doi: 10.1038/386827a0. Nature. 1997. PMID: 9126740 - Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies.
Volkow ND, Fowler JS, Wang GJ. Volkow ND, et al. Behav Pharmacol. 2002 Sep;13(5-6):355-66. doi: 10.1097/00008877-200209000-00008. Behav Pharmacol. 2002. PMID: 12394411 Review. - Rapid regulation of the dopamine transporter: role in stimulant addiction?
Zahniser NR, Sorkin A. Zahniser NR, et al. Neuropharmacology. 2004;47 Suppl 1:80-91. doi: 10.1016/j.neuropharm.2004.07.010. Neuropharmacology. 2004. PMID: 15464127 Review.
Cited by
- Co-targeting the kappa opioid receptor and dopamine transporter reduces motivation to self-administer cocaine and partially reverses dopamine system dysregulation.
Estave PM, Albertson SE, Karkhanis AN, Jones SR. Estave PM, et al. Sci Rep. 2024 Mar 18;14(1):6509. doi: 10.1038/s41598-024-53463-9. Sci Rep. 2024. PMID: 38499566 Free PMC article. - The neurobiology of aesthetic chills: How bodily sensations shape emotional experiences.
Schoeller F, Jain A, Pizzagalli DA, Reggente N. Schoeller F, et al. Cogn Affect Behav Neurosci. 2024 Aug;24(4):617-630. doi: 10.3758/s13415-024-01168-x. Epub 2024 Feb 21. Cogn Affect Behav Neurosci. 2024. PMID: 38383913 Free PMC article. Review. - Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician.
Barbuti M, Maiello M, Spera V, Pallucchini A, Brancati GE, Maremmani AGI, Perugi G, Maremmani I. Barbuti M, et al. J Clin Med. 2023 Apr 24;12(9):3096. doi: 10.3390/jcm12093096. J Clin Med. 2023. PMID: 37176536 Free PMC article. Review. - Symptoms, Mechanisms, and Treatments of Video Game Addiction.
Mohammad S, Jan RA, Alsaedi SL. Mohammad S, et al. Cureus. 2023 Mar 31;15(3):e36957. doi: 10.7759/cureus.36957. eCollection 2023 Mar. Cureus. 2023. PMID: 37009362 Free PMC article. Review. - Intermittent access cocaine self-administration produces context-specific escalation and increased motivation.
Beasley MM, Tunstall BJ, Kearns DN. Beasley MM, et al. Drug Alcohol Depend. 2023 Apr 1;245:109797. doi: 10.1016/j.drugalcdep.2023.109797. Epub 2023 Feb 4. Drug Alcohol Depend. 2023. PMID: 36801708 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical